CAMBRIDGE, Mass. and BOULDER, Colo., Oct. 7, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback